Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nykode Therapeutics ASA Director's Dealing 2021

Sep 20, 2021

3695_dirs_2021-09-20_feca3ec7-7fae-4ee8-9782-5718a05f595e.html

Director's Dealing

Open in viewer

Opens in your device viewer

Vaccibody AS - Mandatory notification of intra group transfer of shares by primary insider’s related party

Vaccibody AS - Mandatory notification of intra group transfer of shares by primary insider’s related party

Oppenheim AS has today sold 300,000 shares in Vaccibody AS to Axe Invest AS at NOK 71 per share. Following the transaction, Oppenheim AS holds no shares and Axe Invest AS holds 300,000 shares in Vaccibody AS.

Oppenheim AS and Axe Invest AS are 100% owned by Karoline Steiro, a closely associated person of Jan Haudemann-Andersen, member of the board of Vaccibody AS.

Please see further details in attached documents.